P. Mizon et al., IMMUNOHEMATOLOGIC SURVEY DURING ABO-INCOM PATIBLE BONE-MARROW TRANSPLANTATION, Transfusion clinique et biologique, 1(4), 1994, pp. 271-277
Direct an antiglobulin test (DAT), ABO typing and isoagglutinins titer
s were regularly performed in 26 patients who received a marrow transp
lant from a major ABO incompatible donor (M = 10 cases), from a minor
ABO incompatible donor (m = 10 cases) or both (B = 6 cases). Erythrocy
te or plasma depletion of bone marrow infusate was used in all major o
r certain minor ABO incompatibilities respectively. A positive DAT was
recorded in 19/26 patients at various times, but only a few of them,
belonging to groups M or B, exhibited a significant hemolysis. No seri
ous complication was observed after bone marrow infusion. Five patient
s showed evidence of hemolysis after transplantation, 1 patient died w
ith a graft rejection and 3 patients had a delayed erythropoietic engr
aftment. In all cases of major ABO incompatibility, the erythrocyte re
covery was preceeded by a decrease of antibodies against the donor's b
lood group. These antibodies finally disappeared in all patients excep
t one who had a persistence of isoagglutinins beyond day + 650. A tran
sient appearance of isoagglutinins against the recipient blood group w
as sometimes detected in minor ABO incompatibility without any clinica
l complications.